Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Schmitz

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Drug and Alcohol Abuse|March 27, 2009
Mindfulness-based stress reduction in therapeutic community treatment: a stage 1 trialMarianne T Marcus, Joy Schmitz, Gerald Moeller, et al.
Addiction (Abingdon, England)|November 27, 2023
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trialJonathan B Bricker, Margarita Santiago-Torres, Kristin E Mull, et al.
Nursing Research|May 15, 2007
Behavioral therapies trials: a case exampleMarianne T Marcus, Patricia R Liehr, Joy Schmitz, et al.
JMIR Research Protocols|April 8, 2026
The Effects of Orexin Receptor Antagonism During Early Withdrawal in Stimulant Use Disorder: Protocol for a Proof-of-Concept StudyHeather Webber, Nikky Tran, Rita Blake, et al.
BMJ Open|May 20, 2026
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trialLuba Yammine, Francesco Versace, Charles E Green, et al.
Neuropsychiatric Disease and Treatment|June 28, 2023
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR<sub>16</sub>) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized TrialJoseph M Trombello, Alexandra Kulikova, Taryn L Mayes, et al.
The Journal of Clinical Psychiatry|August 6, 2025
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 TrialManish K Jha, Udi E Ghitza, Steve Shoptaw, et al.
Journal of Addiction Medicine|January 24, 2020
Association Between Recent Cannabis Consumption and Withdrawal-Related Symptoms During Early Abstinence Among Females With Smoked Cocaine Use DisorderThiago Wendt Viola, Breno Sanvicente-Vieira, Bruno Kluwe-Schiavon, et al.
The New England Journal of Medicine|January 26, 2021
Bupropion and Naltrexone in Methamphetamine Use DisorderMadhukar H Trivedi, Robrina Walker, Walter Ling, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Drug and Alcohol Abuse|March 27, 2009
Mindfulness-based stress reduction in therapeutic community treatment: a stage 1 trialMarianne T Marcus, Joy Schmitz, Gerald Moeller, et al.
Addiction (Abingdon, England)|November 27, 2023
Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trialJonathan B Bricker, Margarita Santiago-Torres, Kristin E Mull, et al.
Nursing Research|May 15, 2007
Behavioral therapies trials: a case exampleMarianne T Marcus, Patricia R Liehr, Joy Schmitz, et al.
JMIR Research Protocols|April 8, 2026
The Effects of Orexin Receptor Antagonism During Early Withdrawal in Stimulant Use Disorder: Protocol for a Proof-of-Concept StudyHeather Webber, Nikky Tran, Rita Blake, et al.
BMJ Open|May 20, 2026
Repurposing semaglutide as an adjunctive treatment for cocaine use disorder: protocol for a randomised controlled trialLuba Yammine, Francesco Versace, Charles E Green, et al.
Neuropsychiatric Disease and Treatment|June 28, 2023
Psychometrics of the Concise Health Risk Tracking Self-Report (CHRT-SR<sub>16</sub>) Assessment of Suicidality in a Sample of Adults with Moderate to Severe Methamphetamine Use Disorder: Findings from the ADAPT-2 Randomized TrialJoseph M Trombello, Alexandra Kulikova, Taryn L Mayes, et al.
The Journal of Clinical Psychiatry|August 6, 2025
Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 TrialManish K Jha, Udi E Ghitza, Steve Shoptaw, et al.
Journal of Addiction Medicine|January 24, 2020
Association Between Recent Cannabis Consumption and Withdrawal-Related Symptoms During Early Abstinence Among Females With Smoked Cocaine Use DisorderThiago Wendt Viola, Breno Sanvicente-Vieira, Bruno Kluwe-Schiavon, et al.
The New England Journal of Medicine|January 26, 2021
Bupropion and Naltrexone in Methamphetamine Use DisorderMadhukar H Trivedi, Robrina Walker, Walter Ling, et al.
Pageof 2